Effects on Growth of an Extensively Hydrolyzed Formula Fed to Term

A 16-Week Growth Study of an Extensively Hydrolyzed Infant Formula, 3 Months Treatment and 1 Month Follow-up for a Duration of 4 Months.

The purpose of this study is to assess growth in infants who are fed an extensively hydrolyzed formula.

Inclusion Criteria:

• At birth:

  • Healthy, term (37-42 weeks) infant
  • Weight for length between the 10th and 90th percentile according to the National Center for Health Statistics (NCHS) growth charts

• At time of enrollment:

  • < or = 21 days post-natal age
  • Weight for length between the 10th and 90th percentile according to the National Center for Health Statistics (NCHS) growth charts
  • Exclusively formula fed
  • Written informed consent of parent/guardian

Exclusion Criteria:

• At the time of enrollment: partially human-milk fed; fed baby/solid foods
• Conditions requiring feedings other than those specified in the protocol
• Documented or suspected cow's milk allergy and/or soy protein allergies
• Major congenital deformities
• Suspected or documented systemic or congenital infections
• Evidence of cardiac, respiratory, hematological, gastrointestinal, or other systemic diseases
• Participation in any other clinical trial